Literature DB >> 3354197

Formation of transmembraneous hepatitis B e-antigen by cotranslational in vitro processing of the viral precore protein.

V Bruss1, W H Gerlich.   

Abstract

The gene encoding the major core protein P22c of hepatitis B virus is preceded by a precore sequence. Expression of the core gene with the precore in Escherichia coli results in a membrane protein of HBe antigenicity. Expression in mammalian cells generates secreted HBeAg. To study the biosynthetic pathway of HBeAg and the function of precore in this process, we translated mRNAs for core proteins with and without precore using reticulocyte lysates and microsomal vesicles. The precore sequence was cleaved cotranslationally as a signal peptide, probably at alanine 19. The processed product P23e was partially translocated to the lumen of the microsomes. The arginine-rich carboxy-terminal domain of P23e was however not translocated and susceptible to trypsin. Clusters of positive-charged amino acids seem to act as a novel type of translocation stop signal. Trypsin generated a P16e which no longer had a transmembraneous configuration. The findings may explain the biosynthesis and potential function of HBeAg in hepatitis B virus-infected hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3354197     DOI: 10.1016/0042-6822(88)90266-8

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  39 in total

1.  Molecular analysis of an auxin binding protein gene located on chromosome 4 of Arabidopsis.

Authors:  K Palme; T Hesse; N Campos; C Garbers; M F Yanofsky; J Schell
Journal:  Plant Cell       Date:  1992-02       Impact factor: 11.277

2.  Biosynthesis of the secretory core protein of duck hepatitis B virus: intracellular transport, proteolytic processing, and membrane expression of the precore protein.

Authors:  H J Schlicht
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.

Authors:  S L Tsai; P J Chen; M Y Lai; P M Yang; J L Sung; J H Huang; L H Hwang; T H Chang; D S Chen
Journal:  J Clin Invest       Date:  1992-01       Impact factor: 14.808

4.  Point mutations upstream of hepatitis B virus core gene affect DNA replication at the step of core protein expression.

Authors:  Michael Guarnieri; Kyun-Hwan Kim; Genie Bang; Jisu Li; Yonghong Zhou; Xiaoli Tang; Jack Wands; Shuping Tong
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Proteolytic conversion of hepatitis B virus e antigen precursor to end product occurs in a postendoplasmic reticulum compartment.

Authors:  J Wang; A S Lee; J H Ou
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  Characterization of nuclear localization of a hepatitis B virus precore protein derivative P22.

Authors:  C T Yeh; L H Hong; J H Ou; C M Chu; Y F Liaw
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

7.  Hepatitis B virus p25 precore protein accumulates in Xenopus oocytes as an untranslocated phosphoprotein with an uncleaved signal peptide.

Authors:  S Q Yang; M Walter; D N Standring
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

8.  Characterization of humoral and CD4+ cellular responses after genetic immunization with retroviral vectors expressing different forms of the hepatitis B virus core and e antigens.

Authors:  M Sällberg; K Townsend; M Chen; J O'Dea; T Banks; D J Jolly; S M Chang; W T Lee; D R Milich
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

9.  Transport of hepatitis B virus precore protein into the nucleus after cleavage of its signal peptide.

Authors:  J H Ou; C T Yeh; T S Yen
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

10.  Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen.

Authors:  H Okamoto; F Tsuda; Y Akahane; Y Sugai; M Yoshiba; K Moriyama; T Tanaka; Y Miyakawa; M Mayumi
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.